Attention-deficit hyperactivity disorder medical therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Added 'Monitoring response to treatment')
Line 22: Line 22:
*Parents may also find it helpful to learn stress management techniques, which could increase their ability to productively deal with their [[frustration]] and enable them to interact with their child in a calm manner.
*Parents may also find it helpful to learn stress management techniques, which could increase their ability to productively deal with their [[frustration]] and enable them to interact with their child in a calm manner.
*[[Support groups]] can assist the parents and families of ADHD patients by connecting them with others who have similar problems and concerns. Groups often meet regularly to share frustrations and successes, to exchange information about recommended specialists and strategies, and to talk with experts.<ref name="#1">National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."</ref>
*[[Support groups]] can assist the parents and families of ADHD patients by connecting them with others who have similar problems and concerns. Groups often meet regularly to share frustrations and successes, to exchange information about recommended specialists and strategies, and to talk with experts.<ref name="#1">National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."</ref>
==Monitoring response to treatment==
Methods of monitoring treatment for ADHD have been reviewed.<ref name="pmid28184164">{{cite journal| author=Ramsay JR| title=Assessment and monitoring of treatment response in adult ADHD patients: current perspectives. | journal=Neuropsychiatr Dis Treat | year= 2017 | volume= 13 | issue=  | pages= 221-232 | pmid=28184164 | doi=10.2147/NDT.S104706 | pmc=5291336 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28184164  }} </ref>
One method is the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS). The WRAADDS has been validated in a clinician administered format<ref name="pmid23647041">{{cite journal| author=Marchant BK, Reimherr FW, Robison D, Robison RJ, Wender PH| title=Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale. | journal=Psychol Assess | year= 2013 | volume= 25 | issue= 3 | pages= 942-50 | pmid=23647041 | doi=10.1037/a0032797 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23647041  }} </ref> and a self-administered format<ref name="pmid26554368">{{cite journal| author=Marchant BK, Reimherr FW, Wender PH, Gift TE| title=Psychometric properties of the Self-Report Wender-Reimherr Adult Attention Deficit Disorder Scale. | journal=Ann Clin Psychiatry | year= 2015 | volume= 27 | issue= 4 | pages= 267-77; quiz 278-82 | pmid=26554368 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26554368  }} </ref>. The self-administered version typically reports about 2 points higher than the clinician adminsitered version. The WRAADDS asks 30 questions in 7 domains, each with Cronbach alpha > 0.7:
# Attention Difficulties
# Hyperactivity/Restlessness
# Temper
# Affective Lability
# Emotional Over-Reactivity
# Disorganization
# Impulsivity
Benchmarks for the self-reported version (SR-WRAADDS) are<ref name="pmid26554368"/>:
* Subjects ''without'' ADHD: 8.5  ± 4.6
* Subjects ''with'' ADHD: 23.4 ± 4.3
** After treatment, score typically drops by 5 points or effect size (different / standard deviation) of 0.7
Definitions of treatment response or 'normalization' include<ref name="pmid28184164">{{cite journal| author=Ramsay JR| title=Assessment and monitoring of treatment response in adult ADHD patients: current perspectives. | journal=Neuropsychiatr Dis Treat | year= 2017 | volume= 13 | issue=  | pages= 221-232 | pmid=28184164 | doi=10.2147/NDT.S104706 | pmc=5291336 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28184164  }} </ref>:
* "Follow-up scores falling within 1.0 standard deviation of the normal mean". For example, SR-WRAADD of less than 13.1
* "30% reduction in symptoms" or score


==References==
==References==

Revision as of 02:35, 20 September 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2], Haleigh Williams, B.S.

Attention-deficit hyperactivity disorder Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Attention-Deficit Hyperactivity Disorder from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Psychiatric Examination

Laboratory Findings

Imaging Findings

Treatment

Medical Therapy

Psychotherapy

Brain Stimulation Therapy

Cost-Effectiveness of Therapy

Monitoring Response to Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:Attention-deficit hyperactivity disorder On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Attention-deficit hyperactivity disorder medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Attention-deficit hyperactivity disorder medical therapy

CDC on Attention-deficit hyperactivity disorder medical therapy

Attention-deficit hyperactivity disorder medical therapy in the news

Blogs on Attention-deficit hyperactivity disorder medical therapy

Directions to Hospitals Treating Attention-deficit hyperactivity disorder

Risk calculators and risk factors for Attention-deficit hyperactivity disorder medical therapy

Overview

The mainstay of therapy for ADHD is the administration of such stimulants as Ritalin and Adderall. While there is no cure for ADHD, currently available treatments can help reduce symptoms and improve functioning. Other treatment options include psychotherapy, education and training, or a combination of therapies.[1]

Medical Therapy

Several different types of medications may be prescribed to mitigate the symptoms associated with ADHD.

  • Stimulants, such as Ritalin and Adderall, are used to increase the patient’s supply of the brain chemicals dopamine and norepinephrine, which play essential roles in thinking and attention.[1] Ritalin is safe and effective in preschool-aged children suffering from ADHD so long as they are closely monitored while taking the drug.[2]
  • Other drugs, including anti-depressants, may also be prescribed in cases of ADHD depending on the patient’s co-morbidities.[1]
  • Atomoxetine is a selective norepinepherine reuptake inhibitor (SNRI) approved for the management of ADHD. It is effective in adult ADHD and is often favored due to lack of abuse potential. While it is non-inferior to methylphenidate in children, its adverse effects in children and adolescents render it a less favorable treatment option.[3][4]

Psychotherapy

  • ADHD can be treated with several types of psychological interventions.
  • Behavioral therapy aims to help a patient change his or her conduct. This type of treatment might involve practical assistance, such as help organizing tasks or completing schoolwork, or working through emotionally difficult events. Behavioral therapy also teaches a person how to: 1) monitor his/her own behavior and 2) give oneself praise or rewards for behaving in a certain desired way.
  • Physicians may also recommend family and marital therapy for the parents, siblings, or spouses of ADHD patients. This type of intervention is aimed at helping family members and loved ones find constructive ways to handle disruptive behaviors, to encourage positive behavioral changes, and to improve interactions with the patient.[1]

Education and training

  • Educating the patient and his or her family members can prove useful in combating the negative effects of ADHD. For the parents or guardians of young patients, parenting skills training can help teach them the skills they need to encourage and reward positive behaviors in their children. Such training helps parents learn how to use a system of rewards and consequences to change a child’s behavior. In this intervention, parents are taught to give immediate and positive feedback for behaviors they want to encourage, and ignore or redirect behaviors that they want to discourage.
  • Parents may also find it helpful to learn stress management techniques, which could increase their ability to productively deal with their frustration and enable them to interact with their child in a calm manner.
  • Support groups can assist the parents and families of ADHD patients by connecting them with others who have similar problems and concerns. Groups often meet regularly to share frustrations and successes, to exchange information about recommended specialists and strategies, and to talk with experts.[1]

Monitoring response to treatment

Methods of monitoring treatment for ADHD have been reviewed.[5]

One method is the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS). The WRAADDS has been validated in a clinician administered format[6] and a self-administered format[7]. The self-administered version typically reports about 2 points higher than the clinician adminsitered version. The WRAADDS asks 30 questions in 7 domains, each with Cronbach alpha > 0.7:

  1. Attention Difficulties
  2. Hyperactivity/Restlessness
  3. Temper
  4. Affective Lability
  5. Emotional Over-Reactivity
  6. Disorganization
  7. Impulsivity

Benchmarks for the self-reported version (SR-WRAADDS) are[7]:

  • Subjects without ADHD: 8.5 ± 4.6
  • Subjects with ADHD: 23.4 ± 4.3
    • After treatment, score typically drops by 5 points or effect size (different / standard deviation) of 0.7

Definitions of treatment response or 'normalization' include[5]:

  • "Follow-up scores falling within 1.0 standard deviation of the normal mean". For example, SR-WRAADD of less than 13.1
  • "30% reduction in symptoms" or score

References

  1. 1.0 1.1 1.2 1.3 1.4 National Institute of Mental Health (NIH). (2016). "Attention Deficit Hyperactivity Disorder."
  2. Riddle MA, Yershova K, Lazzaretto D, Paykina N, Yenokyan G, Greenhill L; et al. (2013). "The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up". J Am Acad Child Adolesc Psychiatry. 52 (3): 264–278.e2. doi:10.1016/j.jaac.2012.12.007. PMC 3660093. PMID 23452683. Review in: Evid Based Ment Health. 2013 Aug;16(3):63
  3. Garnock-Jones KP, Keating GM (2009). "Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents". Paediatr Drugs. 11 (3): 203–26. doi:10.2165/00148581-200911030-00005. PMID 19445548.
  4. Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D (2003). "Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies". Biol. Psychiatry. 53 (2): 112–20. PMID 12547466.
  5. 5.0 5.1 Ramsay JR (2017). "Assessment and monitoring of treatment response in adult ADHD patients: current perspectives". Neuropsychiatr Dis Treat. 13: 221–232. doi:10.2147/NDT.S104706. PMC 5291336. PMID 28184164.
  6. Marchant BK, Reimherr FW, Robison D, Robison RJ, Wender PH (2013). "Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale". Psychol Assess. 25 (3): 942–50. doi:10.1037/a0032797. PMID 23647041.
  7. 7.0 7.1 Marchant BK, Reimherr FW, Wender PH, Gift TE (2015). "Psychometric properties of the Self-Report Wender-Reimherr Adult Attention Deficit Disorder Scale". Ann Clin Psychiatry. 27 (4): 267–77, quiz 278-82. PMID 26554368.


Template:WH Template:WS